In this report, we describe the purification of a novel protease with dual biological actions from germ cell-conditioned medium (GCCM) where germ cells were isolated from adult rat testes using a mechanical procedure. Using multiple HPLC columns and two sequential high performance electrophoresis chromatography steps in association with an [
I]-testin, a Sertoli cell secretory product that is localized at the intertesticular cell junction and is resistant to tryptic digest, was found capable of hydrolyzing testin dose dependently. The proteolysis of [
125 I]-testin by this 41-kDa protein was inhibited by ␣ 2 -macroglobulin (a Sertoli cell secretory product) also in a dose-dependent manner. A study on the interactions between different classes of protease inhibitors and the purified 41-kDa protein revealed that it is a serine protease. At doses ranging between 0.5 and 50 ng/ml, 41-kDa-P induced a dose-dependent inhibition of Sertoli cell secretory function using testin and clusterin as markers without any apparent proteolytic activity. However, at doses greater than 0.5 g/ml, 41-kDa-P was found to cleave [
I]-collagen and [
125 I]-testin at physiological pH, indicating that this 41-kDa protein has dual biological activities whose primary action is concentration dependent. In view of the biological activities of this protease, it is postulated that this protein may be involved in facilitating germ cell migration in the epithelium. (Endocrinology 138: 3259 -3268, 1997) T HROUGHOUT SPERMATOGENESIS, developing germ cells, apart from undergoing intracellular biochemical and molecular transformations during meiotic division, must progressively migrate from the basal lamina to the adluminal compartment where mature spermatozoa are released into the seminiferous tubular lumen. Specialized intertesticular cell junctions must be continuously disrupted and regenerated in a highly coordinated fashion to allow germ cell migration in the epithelium. Thus, it is conceivable that signaling molecules, proteases, protease inhibitors, and cell junction components are involved in these events. Sertoli cells have been known to secrete or express the messenger RNA (mRNA) of multiple proteases or protease activators such as cathepsin L (1, 2), collagenase (type IV) (3), plasminogen activator (4), cathepsins B, C, D, H, L, and S (5); protease inhibitors such as ␣ 2 -macroglobulin (6, 7), TIMP-2 (8, 9), TIMP-1 (8) , cystatin C (10); and cell junction-associated proteins such as actin, vinculin (11) , zonula occludens 1 (ZO-1) (12) , N-cadherin (13, 14) , and testin (15) (16) (17) .
Recent studies on the expression of rat cathepsin L mRNA and its protein localization by immunohistochemical techniques in different stages of the spermatogenic cycle have shown that this cysteine protease is predominantly present in stages Vl-VII of the cycle preceding spermiation, suggesting that it may be involved in the degradation of cell adhesion molecules between mature spermatids and Sertoli cells, thereby facilitating the release of spermatids into the seminiferous tubular lumen (1, 18) . Proteases are known to participate in tissue remodeling in the testis (for review, see Ref. 19 ) and in other organs such as in the ovary during ovulation (for review, see Ref. 20) and during tumorigenesis (for review, see Ref. 21) . Moreover, specific proteolysis of tight junctions has been postulated to be responsible for the translocation of spermatocytes across the blood-testis barrier (4, 22) . During the past decade, studies from several laboratories have demonstrated that germ cells release or express several signaling molecules that modulate Sertoli cell secretory functions such as: 1) basic fibroblast growth factor (FGF) derived from pachytene spermatocytes that stimulates Sertoli cell transferrin expression (23); 2) nerve growth factor (NGF) that was localized in germ cells of the testis (24) has been shown to be a potent mitogen secreted by round spermatids that may participate in germ cell proliferation during spermatogenesis (25) ; and 3) germ cells are known to express interferon-␣ and -␥ (26), among others. However, in a painstaking effort to purify a potent biological factor from germ cellconditioned medium (GCCM) that modulates Sertoli cell clusterin and testin secretion, it was found to be the residual trypsin that was used initially to isolate germ cells from the tubules rather than a putative germ cell factor (27) . The use of trypsin for the isolation of highly purified germ cells for in vitro studies was an accepted procedure used by many laboratories including ours (28 -30) . Other studies have shown that trypsin can also induce changes on the adhesion and binding properties of spermatogenic cells (31) . In the current study, we report the identification, purification, and characterization of a factor from GCCM where germ cells were isolated from the rat testis by a mechanical procedure without the use of trypsin (27) . This protein was found to possess dual biological actions that affect Sertoli cell secretory function or cleaves multiple proteins depending on its concentration in the in vitro assay.
Materials and Methods Biochemicals
Bolton-Hunter reagent (N-succinimidyl 3-(4-hydroxy 5-[ 125 I)-iodophenyl)propionate (specific activity, 3024 -3320 Ci/mmol) was obtained from Amersham (Arlington Heights, IL). Trypsin, collagenase, hyaluronidase, soybean trypsin inhibitor (STI), bacitracin, deoxyribonuclease 1 (DNase 1), L(ϩ)sodium lactate, sodium pyruvate, and 3-[cyclohexylamino]-1-propanesulfonic acid (CAPS), 4-(2-amino ethyl)benzene sulfonyl fluoride (ABSF), sodium p-hydroxymercuribenzoate (sodium p-chloromercuribenzoate), pepstatin, and 1,10-phenanthroline were obtained from Sigma Chemical Co. (St. Louis, MO). Ham's F-12 nutrient mixture and DMEM (F12/DMEM, 1:1, vol/vol) was from GIBCO-BRL (Gaithersburg, MD). Calf skin collagen and miracloth were obtained from Calbiochem (La Jolla, CA). Nylon mesh (20 and 100 m) was from Swiss Silk (Zurich, Switzerland).
GCCM preparation
GCCM was prepared by a nonenzymatic mechanical method as previously described (27, 32) using testes from adult Sprague-Dawley rats (250 -300 g BW). The purity of germ cells isolated by this procedure was assessed by DNA flow cytometry and direct microscopic examination. Both approaches did not reveal any observable somatic cell contaminations (27) . Moreover, when total RNA (about 1 g) extracted from these germ cell preparations was used for RT-PCR to detect testin, an authentic Sertoli and Leydig cell product, it failed to amplify the testin complementary DNA (16, 27) , suggesting the somatic cell contamination is almost negligible. The recovered cells were reconstituted in Ham's F12/DMEM supplemented with 1.2 g/liter sodium bicarbonate, 15 mm HEPES, gentamycin (20 mg/liter), 6 mm sodium DL-lactate, 2 mm sodium pyruvate, and bacitracin (5 g/ml, a protease inhibitor) and plated at a concentration of 2.5 ϫ 10 6 cells/ml in 75 cm 2 culture flasks in a final volume of 15 ml. Cells were incubated at 35 C in 95% air/5% CO 2 (vol/vol) for 20 h. Under these conditions, the cell viability was greater than 90% at the end of the 20-h culture period when examined by erythrosine red dye exclusion test. The spent medium was carefully decanted and centrifuged successively at 800 ϫ g (1 h) and 5000 ϫ g (1 h) to remove residual germ cells. The supernatant was stored at Ϫ20 C until used.
Iodination of collagen
Collagen obtained commercially was purified to apparent homogeneity by reversed-phase HPLC using a Vydac C4 (4.6 ϫ 250 mm, id) column. About 600 g of collagen was suspended in 200 l of the solvent A [5% acetonitrile (ACN)/95% water (vol/vol), containing 0.1% trifluoroacetic acid (TFA, vol/vol)], and loaded onto the C4 column. Proteins were eluted using a linear gradient of 20 -80% solvent B [95% ACN/5% water, containing 0.1% TFA] at a flow rate of 1 ml/min over a period of 45 min. Fractions of 0.5 ml each were collected, and an aliquot from each fraction was resolved by SDS-PAGE onto 5% T SDS-polyacrylamide gels under reducing conditions. For iodination, approximately 5 g of purified collagen recovered by lyophilization was resuspended in iodination buffer (50 mm sodium acetate, 0.15 m NaCl, 0.05% NaN 3 , pH 5.0, at 22 C) and radiolabeled using Na-[
125 I] by Iodogen (33) . Radiolabeled collagen was separated from the free isotope by Sephadex G-100 chromatography using the iodination buffer as the elution buffer.
Detection of 41-kDa-P by a protease assay
To detect protease activity in GCCM, a collagen thin film assay was used as previously described (34) . Briefly, [
125 I]-collagen, about 30,000 cpm, suspended in 25 l of the iodination buffer was coated onto the bottom of 96-multiwell flat-bottom cell culture plates by incubating the plates at 37 C for 3-6 h under humidified conditions. Unattached [
125 I]-collagen was removed by immersing the plates in a water tray for 30 min before air drying at room temperature overnight. About ten such 96-well plates were routinely prepared at a time that remained stable for approximately 4 -6 weeks. A standard curve was generated in each protease assay by incubating the 
Hydrolysis of [ 125 I]-collagen by 41-kDa-P in the presence of protease inhibitors
To determine the protease class of 41-kDa-P, multiple protease inhibitors at various concentrations were used as follows: ABSF (a serine protease inhibitor), sodium chloromercuribenzoate (a cysteine protease inhibitor), pepstatin (an aspartyl protease inhibitor), EDTA (a metalloprotease inhibitor), and 1,10-phenanthroline (a metalloprotease inhibitor). ABSF, pepstatin, and 1,10-phenanthroline were dissolved in ethanol and appropriate controls were run using ethanol without protease inhibitors. EDTA and sodium chloromercuribenzoate were dissolved in PBS (10 mm sodium phosphate, 0.15 m NaCl, pH 8.0, at 22 C). Protease assay was performed as described above except that appropriate amounts of each protease inhibitor was added to triplicate wells before the addition of purified 41-kDa-P.
Purification of 41-kDa-P from GCCM
GCCM, in batches of 5-15L, was concentrated and equilibrated in 20 mm Tris, pH 7.4, at 4 C using a Millipore Minitan tangential ultrafiltration unit (Millipore Corp., Milford, MA) equipped with eight Minitan plates with an M r cut-off at 10,000.
Anion-exchange HPLC. The concentrated and equilibrated sample obtained by ultrafiltration was loaded onto a Mono Q (Pharmacia, Uppsala, Sweden) anion exchange preparative column (HR 16/10, 16 ϫ 100 mm, id; particle size, 10 m) as described (35) at a flow rate of 4 ml/min. Bound proteins were eluted using a linear gradient of 0 -80% solvent B (20 mm Tris, pH 7.4, at 22 C, containing 600 mm NaCl) over a 90-min period. Eluents were monitored by UV absorbance at 280 nm. An aliquot from each fraction was assayed for protease activity and for protein visualization by SDS-PAGE.
Vydac C4 reversed-phase HPLC. Following the preparative anion-exchange HPLC step, fractions exhibiting protease activity were pooled, lyophilized, reconstituted in solvent A [5% ACN/95% water containing 0.1% TFA] and loaded onto a Vydac C4 preparative HPLC column (22 ϫ 250 mm, id; particle size, 10 m) at a flow rate of 4 ml/min. Bound proteins were eluted using a linear gradient of 20 -80% solvent B [95% ACN/5% water, containing 0.1% TFA] over a period of 90 min at a flow rate of 4 ml/min. Eluents were monitored by UV absorbance at 280 nm. Fractions of 4 ml each were collected, lyophilized, resuspended in sterile water, and an aliquot from each fraction was assayed for protease activity and for protein visualization by SDS-PAGE. For all subsequent steps, the compositions of solvents A and B were the same as in this Vydac C4 step unless specified otherwise.
Vydac C8 reversed-phase HPLC. The fractions from the Vydac C4 step that exhibited protease activity were pooled, lyophilized, reconstituted in solvent A and loaded onto a Vydac C8 reversed-phase HPLC column (4.6 ϫ 250 mm, i.d.). Bound proteins were eluted using a linear gradient of 20 -80% solvent B over a period of 45 min at a flow rate of 1 ml/min. Eluted proteins were monitored by UV absorbance at 280 nm. Fractions were lyophilized, resuspended in sterile water, and an aliquot from each fraction was assayed for protease activity and for protein visualization by SDS-PAGE.
Vydac C18 reversed-phase HPLC. The active fractions containing protease activity obtained from the Vydac C8 step were pooled, lyophilized, and fractionated further using a Vydac C18 reversed-phase column (4.6 ϫ 250 mm, id). The lyophilized material was reconstituted in 200 l of solvent A and loaded onto the column at a flow rate of 1 ml/min. Bound proteins were eluted using a linear gradient of 10 -70% solvent B over a period of 45 min at a flow rate of 1 ml/min, and fractions of 0.5 ml each were collected. An aliquot from each fraction was withdrawn, dried under nitrogen, and assayed for protease activity, and proteins visualized by SDS-PAGE.
High performance electrophoresis chromatography (HPEC).
The fractions obtained from the Vydac C18 HPLC step that exhibited protease activity were pooled, lyophilized and resuspended in 50 l of HPEC sample buffer (0.125 m Tris-PO 4 , pH 6.8 at 22 C, containing 10% glycerol and 0.002% bromophenol blue, wt/vol). The sample was loaded onto a 7.5% T polyacrylamide gel of 3.5 ϫ 50 mm (id) in an Applied Biosystems (Foster City, CA) 230A HPEC system as described (36) . Eluents were monitored by UV absorbance at 280 nm, and fractions of about 270 l each were collected. The flow rate of the elution buffer (75 mm Tris-PO 4 , pH 7.5, at 22 C) was about 27 l/min. An aliquot from each fraction was assayed for protease activity, and proteins were visualized by SDS-PAGE. Because the active fractions collected from this HPEC step still contained a few contaminants, they were pooled, concentrated to about 50 l using an Amicon (Danvers, MA) Microcon-3 ultrafiltration unit, suspended in 40 l of the HPEC sample buffer, and further fractionated by a 12.5% T HPEC polyacrylamide gel (3.5 ϫ 50 mm, id) using procedures as described above.
Bioassay of 41-kDa-P
The ability of purified 41-kDa-P to modulate Sertoli cell secretory function was bioassayed using primary cultures of Sertoli cells isolated from 20-day-old Sprague-Dawley rats (28) . Sertoli cells cultured in F12/ DMEM supplemented with insulin (10 g/ml), human transferrin (5 g/ml), epidermal growth factor (2.5 ng/ml), and bacitracin (5 g/ml) were plated in 24-well culture plates at a concentration of 2 ϫ 10 5 cells in 500 l suspension and incubated at 35 C in a humidified atmosphere of 5% CO 2 /95% air. After 48 h, Sertoli cells were subjected to a 2.5-min hypotonic treatment (20 mm Tris, pH 7.4, at 22 C) to lyze contaminating germ cells followed by two additional washes. Twenty-four hours later, aliquots of HPLC/HPEC fractions ranging from 5-50 l from different purification steps were incubated with these cells for an additional 24 h. The spent media were collected for specific RIAs. In some experiments, the cell numbers before and after the 24 h incubation with purified 41-kDa-P were assessed by a Coulter counter. In all cases, cell numbers and viability as monitored by trypan blue dye exclusion test did not change more than 5%.
Effect of different pHs on the proteolytic activity of 41-kDa-P
To examine the optimal pH range required for 41-kDa-P to exert its protease activity, different doses of purified 41-kDa-P were reconstituted in buffers of different pHs similar to the standard protease buffer described above. For pHs at 2.5-5.5, 50 mm Tris was substituted with 50 mm sodium acetate. The pH was adjusted using acetic acid, whereas the other components remained the same (0.2 m NaCl, 1 mm CaCl 2 , 0.02 NaN 3 ). In assays screening for the effect of metalloprotease inhibitors on 41-kDa-P, all metallic cations were omitted in the protease buffer. Aliquots of 0.3 ng-1.5 g of the highly purified 41-kDa-P in duplicate were suspended in each of these buffers in a total volume of 200 l, transferred to [
125 I]-collagen coated wells, and incubated for 3 h at 37 C. Thereafter, 150 l of the supernatant was collected for radioactivity determination.
Proteolysis of [ 125 I]-testin by 41-kDa-P
The ability of 41-kDa-P to cleave testin in vitro was tested under different experimental conditions by incubating [ 125 I]-testin (about 50,000 cpm) at 37 C in the absence or presence of different doses of purified 41-kDa-P in F12/DMEM, protease buffer, Sertoli cell-conditioned medium (SCCM), or RIA buffer (10 mm sodium phosphate, 0.15 m NaCl, pH 7.4, at 22 C containing 0.5% BSA, wt/vol). The rationale for performing these experiments was to assess whether the previously noted inhibition of Sertoli cell testin secretion by fractions of purified 41-kDa-P in the in vitro bioassay was an authentic biological inhibitory activity or an artefact of proteolysis. About 50,000 cpm of [
125 I]-testin was incubated in the absence or presence of 0.01, 0.5, 1, and 1.5 g of purified 41-kDa-P with either F12/DMEM, SCCM, or RIA buffer in a final incubation volume of 75 l in corresponding buffer, and incubated at 37 C for 20 h. We also studied the effect of various doses of ␣ 2 -macroglobulin, a Sertoli-cell secreted protease inhibitor (6), on the proteolytic activity of 41-kDa-P. Hydrolysis of [
125 I]-testin by 41-kDa-P was assessed by SDS-PAGE.
NH 2 -Terminal protein sequencing
Highly purified 41-kDa-P (about 0.1 nmol) was resolved by SDS-PAGE onto 12.5% T SDS-polyacrylamide gels, transferred onto a polyvinylidene difluoride (PVDF) membrane using a buffer system consisting of 10 mm CAPS/10% methanol (vol/vol), pH 11, at 22 C. 41-kDa-P electroblotted onto the PVDF membrane was stained by Coomassie blue R-250 as described (36) and sequenced as detailed elsewhere (35) (36) (37) . In one experiment, purified 41-kDa-P (about 0.1 nmol) obtained from the HPEC step was coated onto a BioBrene coated cartridge and sequenced directly. Phenylthiohydantoin (PTH)-amino acids were identified and quantified by HPLC using a Brownlee PTH-C18 (id, 2.1 ϫ 220 mm; particle size, 5 m) column. The repetitive yield was about 96%. Protein sequencing was repeated five times using different batches of highly purified 41-kDa-P.
Testin RIA
Purified rat testin (about 5 g) was radioiodinated using [
125 I]-BoltonHunter reagent (38) . Testin RIA was performed as previously described (35) . The interassay and intraassay coefficients of variation were 11% and 8%, respectively. The minimal detectable dose was 0.06 ng/assay tube and 50% displacement was at 1.3 ng.
Clusterin RIA
Clusterin RIA was performed as detailed elsewhere (39) . The interassay and intraassay coefficients of variation were 14% and 10%, respectively. The minimal detectable dose was at 0.12 ng/assay tube and the 50% displacement was at 14 ng.
General methods
Analytical PAGE was performed according to the procedures of Laemmli (40) . The resolving gel consisted of 12.5% T (total acrylamide concentration) and 2.6% cross-linker using methylene-bisacrylamide (% C Bis ), with a stacking gel of 5% T and 15% N,N-diallyltartardiamide (% C DATA ). Protein estimation was performed by Coomassie blue dye binding assay using BSA as a standard (41) . Transferrin RIA was performed as detailed elsewhere (28) .
Results
Purification of 41-kDa-P from GCCM. A protease designated 41-kDa-P was purified to apparent homogeneity from a batch of 12L of GCCM (about 70 mg total protein) by sequential HPLC using a preparative anion-exchange col- (Fig. 1A) , a preparative C4 column (Fig. 1B) , an analytical C8 column (Fig. 1C) , an analytical C18 column (Fig.  1D) , and two consecutive HPEC steps using 7.5% (Fig. 1F ) and 12.5% T (Fig. 1H) polyacrylamide gels under nonreducing conditions. In each of the purification steps, 41-kDa-P was assessed by the [ 125 I]-collagen film assay. Each protease assay was accompanied by a calibration curve to ensure assay reliability using increasing doses of trypsin with and 125 I]-collagen thin-film assay using different doses of trypsin with and without STI. B, The active fractions containing protease activity obtained from the Mono Q HPLC step was pooled, lyophilized, and suspended in solvent A [5% ACN/95% water, containing 0.1% TFA]. It was then loaded onto a preparative Vydac C4 reversed-phase HPLC column (22 ϫ 250 mm, id), and the bound proteins were eluted using a linear gradient of 20 -80% solvent B (95% ACN/5% water, containing 0.1% TFA) over a period of 90 min at a flow rate of 4 ml/min. A total of 25 protein peaks were eluted. An aliquot of 20 l from each of these fractions were assayed using [
125 I]-collagen, and the protease activity was detected in fractions 45-55. For all subsequent reversed-phase HPLC steps, unless otherwise noted, the compositions of solvents A and B were the same as this HPLC step. C, The active fractions obtained from the Vydac C4 step were pooled, lyophilized, resuspended in solvent A and loaded onto a Vydac C8 reversed-phase HPLC column (4.6 ϫ 250 mm, id), and the bound proteins were eluted using a linear gradient of 20 -80% solvent B over a period of 45 min at a flow rate of 1 ml/min. A total of 8 protein peaks were noted. When an aliquot of 20 l from each of these fractions were assayed for protease activity, it was noted that the protease was eluted in fractions 32-38 under protein peaks 3-4. D, The active fractions obtained from the above step were pooled, lyophilized, resuspended in solvent A and fractionated onto a Vydac C18 (4.6 ϫ 250 mm, id) reversed-phase column. The bound proteins were eluted using a linear gradient of 10 -70% solvent B over a period of 45 min at a flow rate of 1 ml/min. A total of five protein peaks were seen, and protease activity was detected in fractions 48 -52 under protein peaks 3-4. E, An aliquot of 20 l from selected fractions was resolved by SDS-PAGE onto 12.5% T SDS-polyacrylamide gels to assess protein purity in the active fractions by silver staining. F, The active fractions obtained from the above step were pooled, lyophilized, resuspended in 50 l of HPEC sample buffer and fractionated by HPEC using a 7.5% T polyacrylamide gel of 3.5 ϫ 50 mm (id). Six protein peaks were observed and protease activity was detected in fractions 26 -38. G, An aliquot of 30 l from selected fractions containing protease activity was resolved by SDS-PAGE onto a 12.5% T SDS-polyacrylamide gel under reducing conditions. A protein, which could not be silver stained with an apparent Mr of 41 kDa was noted. H, These proteolytically active fractions were pooled, concentrated by ultrafiltration and further fractionated by HPEC using a 12.5% T polyacrylamide gel (3.5 ϫ 50 mm, id). A total of eight protein peaks were noted in this second HPEC step, and the protease activity was found to be associated with protein peak 7 in the chromatogram.
FIG. 1. E-H 41-kDa PROTEIN IS A NEW TESTICULAR PROTEASE
without STI (Fig. 1A, inset) . The inset shown in Fig. 1A demonstrated that trypsin induced dose-dependent proteolysis of [
125 I]-collagen that could be inhibited by STI. Using this protease assay, it was noted that protease activity in GCCM eluted in fractions 20 -38 from the preparative Mono Q HPLC step under protein peaks 6 -10 (Fig. 1A ). The active fractions were then fractionated by sequential C4 (Fig. 1B), C8 (Fig.  1C) , and C18 (Fig. 1D) reversed-phase HPLC columns as detailed in Materials and Methods. When an aliquot of 20 l of sample from selected fractions between 5 and 95 from the C18 reversed-phase HPLC step (Fig. 1D ) was resolved by SDS-PAGE and the proteins visualized by silver staining (Fig. 1E) , the proteolytically active fractions in 48 -52 derived from the C18 HPLC step (Fig. 1D ) still contained multiple contaminating proteins (fractions 48 -52 in Fig. 1E ). These proteolytically active fractions were pooled, concentrated, equilibrated, and further purified by HPEC using a 7.5% T polyacrylamide gel. Protease activity was found in fractions 26 -38 ( Fig. 1F) which, apart from a few contaminating bands, corresponded to a heterogeneous band of 41 kDa under reducing conditions that could not be readily silver stained (Fig. 1G) . To verify that this 41-kDa protein is indeed the protease, it was further purified by HPEC using a 12.5% T polyacrylamide gel (Fig. 1H) . When the proteolytically active fraction was resolved by SDS-PAGE under nonreducing and reducing conditions, a protein band of 44 kDa and 41 kDa, respectively, was noted when stained by Coomassie blue R-250 ( Fig. 2A) . Silver staining was not used for the reason given above (see Fig. 1G ); however, when this gel was visualized with silver staining, no other contaminant was detected (data not shown). An increase in electrophoretic mobility under reducing conditions vs. nonreducing conditions, 41 vs. 44 kDa, can be explained by complete denaturation of the polypeptide chain under reducing conditions that cause linearization of the polypeptide chain and thus a better electrophoretic mobility. Direct N-terminal sequence analysis of purified 41-kDa-P from at least five batches of samples using protein either from the HPEC step (Fig. 1H) or 41-kDa-P electroblotted onto PVDF membrane revealed an identical partial N-terminal sequence of NH 2 -KYEFYEIXLL (Fig. 2B) , suggesting that the protein has been purified to apparent homogeneity. Comparison of this partial N-terminal sequence with existing database at GenBank, PIR, and BLAST revealed that 41-kDa-P is a unique protein. Also, it did not display significant homology to any existing sequences in the protease database. Using the purification scheme described above, we routinely obtained 300 -500 g of purified 41-kDa-P from each 12-15L batch of GCCM. A total of five separate sets of experiments were carried out, and a similar result was obtained in each set of experiments.
Biological activity of 41-kDa-P on Sertoli cell secretory function
Since an earlier investigation from this laboratory has shown that GCCM prepared by trypsinization of the seminiferous tubules to release germ cells yields an unwanted biological artefact caused by the residual exogenous trypsin that inhibits Sertoli cell secretion of transferrin, clusterin, and testin (27), we next sought to investigate whether the purified 41-kDa-P could induce a similar effect. Using increasing concentrations of purified 41-kDa-P between 0.005 and 25 ng/500 l/dish in the bioassay with primary cultures of Sertoli cells, 41-kDa-P was shown to inhibit the secretion of both testin (Fig. 3A) and clusterin (Fig. 3B) dose dependently, whose inhibitory effect became visible at a dose of about 0.25 ng/500 l/dish with an ED 50 at 0.5-1.5 ng/500 l/dish. A similar observation was achieved using two different batches of purified 41-kDa-P. The observed biological effect of 41-kDa-P on Ser -FIG. 2. A and B , Structural analysis of the purified 41-kDa-P. A, About 1.5 g of purified 41-kDa-P isolated from GCCM as described in Fig.  1H was resolved by SDS-PAGE onto a 12.5% T SDS-polyacrylamide gel under nonreducing (lane 2) and reducing (lane 4) conditions showing a protein with an apparent Mr of 44 and 41 kDa, respectively. Because this protein could not be visualized by silver staining possibly due to its high carbohydrate content, the gel was stained with Coomassie blue. Lanes 1 and 3 are prestained Mr markers (BRL) containing 2.5 g each of BSA (Mr, 68,000), ovalbumin (Mr, 45,000), carbonic anhydrase (Mr, 31,000), soybean trypsin inhibitor (Mr, 21,500), and lysosome (Mr, 14,400). This analysis revealed that the purified 41-kDa-P is a single polypeptide chain. B, About 100 pmol of the purified 41-kDa-P was subjected to direct protein sequencing and 10 amino acids were identified from its N-terminus. X represents an amino acid that cannot be unequivocally assigned. Protein sequencing was performed as described in Materials and Methods. The abscissa represents the residue number from each Edman degradation cycle; the ordinate represents the PTH-derivative obtained from each cycle. The reported sequence and the yield from each cycle of the first ten amino acids were the results of one sequencing experiment. Five separate batches of purified 41-kDa-P yielded identical results.
toli cell testin and clusterin secretion does not appear to be the result of nonspecific proteolysis. Because in the bioassay using primary Sertoli cell cultures, 5 g of bacitracin/ml was included in the F12/DMEM that acted as a protease inhibitor. Furthermore, Sertoli cells secreted about 1.5-2 g ␣ 2 -macroglobulin/ml medium in vitro under the present culture conditions when quantified by RIA as previously described (42) . In view of the data reported in Fig. 5 (see below) where 1:1 molar ratio of ␣ 2 -macroglobulin:41-kDa-P is effective in limiting the proteolytic activity of 41-kDa-P, the amount of ␣ 2 -macroglobulin released by Sertoli cells (1.5-2 g/ml) should be sufficient to inhibit the proteolytic activity of 41-kDa-P because the effective biological dose of 41-kDa-P was at 0.5-50 ng/ml (Fig. 3, A and B) .
pH dependence of 41-kDa-P's proteolytic activity
Because 41-kDa-P at doses of 0.25-25 ng/500 l/dish (ϭ0.5-50 ng/ml, Fig. 3, A and B) was effective in modulating Sertoli cell secretory function, we next sought to examine whether it possessed proteolytic activity at these concentrations. We also assessed the optimal pH required for its activity. At the indicated pH values between 2.5 and 5.5, 41-kDa-P did not exhibit any significant proteolytic activity at doses between 0.3 ng and 1.5 g/200 l/assay well (ϭ1.5 ng/ml-7.5 g/ml) (Fig. 4) . At pH 7.4, however, 41-kDa-P cleaved [
125 I]-collagen dose dependently, and the proteolytic activity was detectable only when its concentration was at about 0.1 g/200 l/assay well (ϭ0.5 g/ml) (Fig. 4) . More important, this proteolytic activity was not inhibited by STI indicating 41-kDa-P is different from trypsin (Fig. 4) .
41-kDa-P is a serine protease
Using a battery of protease inhibitors including ABSF (a serine protease inhibitor), sodium chloromercuribenzoate (a cysteine protease inhibitor), pepstatin (an aspartyl protease inhibitor), 1,10-phenanthroline (a metalloprotease inhibitor), and EDTA (a metalloprotease inhibitor) ( Table 1 ) (for review, see Ref. 58 ), we examined their effects on the proteolytic activity of 41-kDa-P using the [ 125 I]-collagen film assay (Table 1). It was found that 41-kDa-P can be inhibited by ABSF but not by the other inhibitors suggesting it is a member of the serine protease family ( Table 1) .
Hydrolysis of [ 125 I]-testin by 41-kDa-P
Testin, a Sertoli cell product resistant to trypsin digest in vitro (17) has recently been shown to be a component of junctional complexes at inter-Sertoli and Sertoli-germ cell junctions in the seminiferous epithelium (15, 16) . Both the protein concentration and the mRNA level of testin are the highest in the testis as compared with other tissues such as the epididymis, brain, kidney, liver, spleen, and liver (17) . Because 41-kDa-P was isolated from GCCM and is apparently a product of germ cells, we sought to examine whether it could hydrolyze testin under various experimental conditions. In both protease buffer (Fig. 5,  lanes 1-5) , and serum-free F12/DMEM (Fig. 5, lanes 6 -10) FIG. 3. A and B, Dose-dependent inhibitory effect of the purified 41-kDa-P on the Sertoli cell secretory function. Different doses of 41-kDa-P were incubated with primary Sertoli cell cultures in 24-well dishes at 2 ϫ 10 5 cells/dish in a suspension of 500 l for 24 h. Spent media were then collected and the concentrations of testin (A) and clusterin (B) were determined by corresponding RIAs. Solid bar, Control cultures without 41-kDa-P; **, significantly different from control using Student's t test, P Ͻ 0.01; ns, not significantly different from control. Identical results were obtained from four separate experiments using different batches of purified 41-kDa-P.
FIG. 4. Effect of different pHs on the cleavage of [
125 I]-collagen by highly purified 41-kDa-P. Increasing amount of highly purified 41-kDa-P from 0.3 ng-1.5 g protein was suspended in either buffer A (50 mM Tris, 0.2 M NaCl, 1 mM CaCl 2 , 0.02% NaN 3 at pH 7.4 at 22 C) or buffer B (50 mM sodium acetate, 0.2 M NaCl, 1 mM CaCl 2 , 0.02% NaN 3 at pH 2.5-5.5 at 22 C) and was incubated with [ 125 I]-collagen in a final reaction volume of 200 l. Protease assay was performed as described in Materials and Methods. It was noted that at pH 7.4, 41-kDa-P yielded a dose-dependent cleavage of collagen that could not be inhibited by 200 g of soybean trypsin inhibitor (STI). However, 41-kDa-P was inactive at pH 2.5-5.5. A representative experiment was shown here, four separate experiments using different batches of purified 41-kDa-P yielded identical results.
41-kDa-P was found to cleave [ 5, lanes 11-15) or SCCM (Fig. 5, lanes 16 -20) . We speculate that the inhibitory effect of SCCM on 41-kDa-P proteolytic activity may be the result of multiple protease inhibitors present in this medium because it is known that Sertoli cells secrete both ␣ 2 -macroglobulin and TIMP-2 when cultured in vitro (6 -9) . Under these culture conditions, Sertoli cells secrete as many as 1.5-2 g of ␣ 2 -macrogloublin/ml medium (42) . We, therefore, sought to examine the effect of ␣ 2 -macroglobulin on the proteolytic action of 41-kDa-P. It was found that ␣ 2 -macroglobulin isolated from a Assays were performed as described in Materials and Methods using the purified 41-kDa protein. Each number represents the result of duplicate determinations of a given experiment. This experiment was repeated twice using two separate batches of purified 41-kDa protein, and similar results were obtained in each experiment. In experiments to assess the effect of metalloprotease inhibitors on 41-kDa protein, the protease buffer was 50 mM Tris, pH 7.4, at 22 C without any metallic cations.
b Controls were run using protease buffer alone. c Controls were run using protease buffer alone plus 10 l ethanol without protease or protease inhibitor. ]-testin (about 50,000 cpm) at 35 C in the corresponding buffer for a 20 h period together with 0, 0.01, 0.5, 1, and 1.5 g of highly purified 41-kDa-P in a final reaction volume of 75 l corresponding to lanes 1-5 and 6 -10, respectively. At the end of the incubation period, an aliquot of 50 l of the media from each treatment group was resolved by SDS-PAGE onto a 12.5% T SDS-polyacrylamide gel, dried, and exposed to x-ray film to assess proteolysis of [ 125 I]-testin. To test whether the inhibition of SC testin secretion was artefactually induced by the hydrolysis of [
125 I]-testin tracer by 41-kDa-P in the RIA despite the presence of BSA in the RIA buffer (0.5% BSA in 10 mM sodium phosphate, 0.15 M NaCl, pH 7.4, at 22 C; as such each RIA assay tube contained about 2.5 mg BSA), the ability of different doses of 41-kDa-P to hydrolyze the tracer in the presence BSA (about 0.375 mg BSA/assay tube/75 l, i.e. at 5 mg/ml) was studied. Lanes 11-15 are the same as lanes 1-5 and 6 -10 except that the protease buffer contained 0.375 mg of BSA in the assay tube which protected the [ 125 I]-testin from being hydrolyzed. To rule out the possibility that the testin or clusterin secreted by Sertoli cells in the bioassay may be hydrolyzed by 41-kDa-P during incubation leading to an apparent but artefactual inhibition as shown in Fig. 3, A and B, the effect of SCCM on 41-kDa-P induced hydrolysis of [ 125 I]-testin was studied (lanes 16 -20) by suspending increasing concentration of 41-kDa-P in SCCM (about 30 l SCCM per incubation tube which contained about 10 g total protein). The lack of hydrolysis indicated the presence of protease inhibitors in SCCM that limited the action of 41-kDa-P. The effect of 5 g of ␣ 2 -MG/assay tube/75 l on 41-kDa-P induced hydrolysis of [ 125 I]-testin was similarly studied (lanes [21] [22] [23] [24] [25] . It is apparent that 5 g of ␣ 2 -MG/assay tube/75 l inhibited the 41-kDa-P induced hydrolysis of [ SCCM is a potent inhibitor of 41-kDa-P (Fig. 5, lanes 21-25) with a dose-dependent inhibitory effect (Fig. 5, lanes 26 -30) . These analyses revealed that 41-kDa-P is likely a germ cell product whose proteolytic activity can be blocked by a Sertoli cell secreted protease inhibitor.
Discussion
41-kDa-P, apart from being a protease, was also found to modulate Sertoli cell testin and clusterin secretion in vitro. At low doses ranging between 0.5 and 50 ng/ml, 41-kDa-P suppressed Sertoli cell secretory function dose-dependently and possessed no proteolytic activity. However, at a dose of 500 ng/ml or greater, it exhibited potent proteolytic activity cleaving both [
125 I]-collagen and [ 125 I]-testin in vitro indicating 41-kDa-P is having dual biological actions in the seminiferous epithelium. This may explain, in retrospect, why our earlier attempts of using a bioassay to assess the effect of GCCM on Sertoli cell secretory function for the purification of a testin inhibitor (27) were met with such a technical difficulty. We had noticed that the use of a Sertoli cell bioassay to monitor 41-kDa-P throughout the purification scheme showed a gradual loss in bioactivity. This can now be explained by the dual nature of this protease because such a decline in bioactivity was associated with an increase in proteolytic activity in successive purification steps. The dual biological activity of this 41-kDa protease does not appear to be the result of contaminating protein(s) because the profile of the biological activity closely matches the protein elution profile in multiple HPLC steps, in particular the last HPEC step making it unlikely that two different proteins would have identical retention times after multiple HPLC and HPEC steps. The proteolytic activity of 41-kDa-P is optimal at a pH of 7.4 that could not be inhibited by STI indicating that it is different from trypsin. The Sertoli cell modulating activity exhibited by 41-kDa-P is unlikely an artefact of proteolysis of the tracers such as [
125 I]-testin or [
125 I]-clusterin within the RIA tubes because the excess BSA present in the RIA buffer (about 2.5 mg BSA/RIA tube) can protect the tracers from being cleaved by 41-kDa-P as demonstrated in the present study. Also, the inhibitory action of 41-kDa-P on Sertoli cell testin and clusterin secretion cannot be attributed to proteolysis of the secreted testin and clusterin in the bioassay because 41-kDa-P's proteolytic activity is inhibited by SCCM. The effective concentration of ␣ 2 -macroglobulin in the spent media of the bioassay is about 1.5-2 g/ml that is sufficient to limit the action of 41-kDa-P because it is present only at a concentration between 0.5 and 50 ng/ml in the bioassay given the fact that ␣ 2 -macroglobulin is capable to limit the action of 41-kDa-P at a molar ratio of 1:1 with 41-kDa-P (Fig. 5) . It is likely that ␣ 2 -macroglobulin is the factor in SCCM that inhibits 41-kDa-P because it was shown to be a putative Sertoli cell secretory product (6) . The maximum concentration of 41-kDa-P used in the bioassay at 50 ng/ml was found neither to affect Sertoli cell viability nor reduce cell number as demonstrated by trypan blue dye exclusion test, measurement of lactic dehydrogenase level, and cell number determination by a Coulter counter. In addition, it is noteworthy to mention that trypsin at a concentration of up to 1 g/ml did not affect Sertoli cells detrimentally (27) .
The fact that 41-kDa-P, a gonadal peptide, has dual biological actions is not without precedence. TIMP-1, a protease inhibitor released by Sertoli cells (8) , has recently been shown to be also a potent stimulator of Leydig cell steroidogenic function (43) . This stimulation is maximal when TIMP-1 forms a molecular aggregate with cathepsin L (43), a cysteine protease actively synthesized and secreted by Sertoli cells (1, 2) . Besides, activin, originally purified from follicular fluid (44, 45) and found to be expressed in Leydig cells (46) , has also been shown to exhibit multiple biological actions. On one hand, activin stimulates the synthesis (47) and release (48) of FSH from the pituitary. On the other hand, activin acts as a mitogen by stimulating mammalian organogenesis (49) and spermatogonial proliferation in vitro (50) . Furthermore, activin can regulate the mRNA expression of follistatin in granulosa cells (51) . Similarly, ␣ 2 -macroglobulin is a protease inhibitor in the testis but is also a binding protein of various growth factors such as TGF-␤ (52, 53) and activin (54) and is also known to stimulate the growth of EC and RME cells in vitro (55, 56) .
Throughout the purification of 41-kDa-P, this protein was found difficult to be visualized by silver staining, possibly due to extensive glycosylation, unless the oligosaccharides were oxidized by periodic acid treatment (data not shown). However, 41-kDa-P can be readily visualized by Coomassie blue staining. The heterogeneity of this protein was also visible by SDS-PAGE, which displayed a rather heterogeneous band on polyacrylamide gel; however, direct protein sequencing of discrete segments within this heterogenous band electroblotted onto PVDF membrane consistently yielded the same N-terminal sequence.
Spermatogenesis is a precisely controlled and timed process that consists of multiple biochemical and molecular events and are inextricably linked to the kinetics of germ cell migration and turnover of intertesticular cell junctions. The demonstration of dual activities of 41-kDa-P, in particular its effect on testin, suggest a likely role for 41-kDa-P in junctional restructuring during spermatogenesis. Testin has been implicated to be a dynamic component of intertesticular cell junctions (15) (16) (17) 57) . The testin mRNA expression appears to be dependent upon the status of tissue restructuring in a given organ (17, 57) . Moreover, the expression of testin is the highest in the gonad possibly due to the continual tissue restructuring as a result of germ cell or follicle development. Even though testin can be cleaved by trypsin at Gln-94 from the N-terminus, it is resistant to further tryptic digest in vitro unless it is exposed to low pH for an extended period of time (17) . 41-kDa-P, on the other hand, is capable of inducing complete proteolysis of testin at physiological pH suggesting this molecule may be important in mediating the action of testin in the epithelium. Even though further investigation is necessary to define the function of this 41-kDa protein, it appears this protein may play a critical role in Sertoli cell-germ cell interactions in the epithelium during spermatogenesis.
